Isovaline

Summary

Isovaline
Isovaline Isovalin.svg
Names
IUPAC name
2-Amino-2-methylbutanoic acid
Other names
2-Amino-2-methylbutyric acid; 2-Ethylalanine; α-Ethylalanine
Identifiers
  • 595-39-1 checkY
  • 3059-97-0 (R) checkY
  • 595-40-4 (S) checkY
3D model (JSmol)
  • Interactive image
ChemSpider
  • 85483
  • 6971275
UNII
  • JUL973T11C checkY
  • IF7U5GXQ28 (R) checkY
  • EBV7H5W26H (S) checkY
  • DTXSID70974906 Edit this at Wikidata
  • InChI=1S/C5H11NO2/c1-3-5(2,6)4(7)8/h3,6H2,1-2H3,(H,7,8)
    Key: GCHPUFAZSONQIV-UHFFFAOYSA-N
  • O=C(O)C(N)(C)CC
Properties
C5H11NO2
Molar mass 117.148 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Isovaline is a rare amino acid transported to earth by the Murchison meteorite, which landed in Australia in 1969. The discovery of isovaline in the biosphere demonstrates an extraterrestrial origin of amino acids and has been linked to the homochirality of life on earth[1] suggesting a role in the origin of life.[2]

The structure of isovaline is similar to the amino acids GABA and glycine, the chief inhibitory neurotransmitters in the mammalian central nervous system. Isovaline acts as an analgesic in mice[3][4] by activating peripheral GABAB receptors.[4][5] In a mouse model of osteoarthritis isovaline restored mobility, suggesting inhibition of nociception by isovaline in the synovial membrane of the mouse knee.[4]

Isovaline does not cross the blood-brain barrier[4] and does not enter into the brain or spinal cord. Drugs such as opioids cross the blood-brain barrier to produce analgesia but often produce in addition confusion, sedation, and addiction.

Isovaline acts downstream to the cyclooxygenase system that NSAIDs inhibit, suggesting a means to avoid adverse effects such as irritation of the gastrointestinal system.

See also

References

  1. ^ J.R. Cronin; S. Pizzarello (1999). "Amino acid enantiomer excesses in meteorites". Origin and Significanca Adv. Space Rex. 23 (2): 293–299. doi:10.1016/s0273-1177(99)00050-2.
  2. ^ Mindy Levine; Craig Scott Kenesky; Daniel Mazori; Ronald Breslow (2008). "Enantioselective Synthesis and Enantiomeric Amplification of Amino Acids under Prebiotic Conditions". Organic Letters. 10 (12): 2433–2436. doi:10.1021/ol8007099. PMID 18491865.
  3. ^ Macleod BA. Wang JT. Chung CC. Ries CR. Schwarz SK. Puil E. (Apr 2010). "Analgesic properties of the novel amino acid, isovaline". Anesthesia & Analgesia. 110 (4): 1206–14. doi:10.1213/ane.0b013e3181d27da2. PMID 20357156. S2CID 24383709.
  4. ^ a b c d Whitehead RA. Puil E. Ries CR. Schwarz SK. Wall RA. Cooke JE. Putrenko I. Sallam NA. Macleod BA. (Jun 28, 2012). "GABA(B) receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline". Neuroscience. 213: 154–60. doi:10.1016/j.neuroscience.2012.04.026. PMID 22525135. S2CID 5421566.
  5. ^ Cooke JE. Mathers DA. Puil E. (Jan 2010). "R-Isovaline: a subtype-specific agonist at GABA(B)-receptors?". Neuroscience. 201: 85–95. doi:10.1016/j.neuroscience.2011.10.049. PMID 22079439. S2CID 23639338.